Physician profile
Sandy M Duncan
NPI 1255336103
$1,225.69
in general payments reported to CMS, 2019-2025
15 companies · $68.96 in 2025
The $68.96 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $538 · 2023: $207 · 2024: $132 · 2025: $68.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $421.77 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $181.79 | 2022-2024 | Watchman, Watchman Flx |
| Janssen Pharmaceuticals, INC | $121.96 | 2021-2024 | Xarelto |
| Pfizer INC. | $90.36 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $81.40 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $63.98 | 2021-2023 | Camzyos |
| Cvrx, INC. | $57.48 | 2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $47.17 | 2023 | Pascal |
| Astrazeneca Pharmaceuticals LP | $45.08 | 2022 | |
| Esperion Therapeutics, INC. | $23.13 | 2024 | Nexletol |
| Kestra Medical Technology Services, INC. | $23.10 | 2023 | Assure Wcd |
| Puma Biotechnology, INC. | $18.36 | 2021 | |
| Amgen INC. | $16.88 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.82 | 2022 | |
| Cardiovascular Systems INC. | $16.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.